Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
Total Valuation
Ascentage Pharma Group International Unsponsored ADR has a market cap or net worth of $2.21B. The enterprise value is ―.
Market Cap$2.21B
Enterprise Value―
Share Statistics
Ascentage Pharma Group International Unsponsored ADR has 87,112,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding87,112,240
Owned by Insiders―
Owned by Institutions0.23%
Financial Efficiency
Ascentage Pharma Group International Unsponsored ADR’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count574
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Ascentage Pharma Group International Unsponsored ADR is ―. Ascentage Pharma Group International Unsponsored ADR’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Ascentage Pharma Group International Unsponsored ADR had revenue of ― and earned -925.64M in profits. Earnings per share was ―.
Revenue―
Gross Profit191.44M
Operating Income-896.50M
Pretax Income―
Net Income-925.64M
EBITDA-839.67M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Ascentage Pharma Group International Unsponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.02
52-Week Price Change41.45%
50-Day Moving Average22.54
200-Day Moving Average―
Relative Strength Index (RSI)51.82
Average Volume (3m)20.43K
Important Dates
Ascentage Pharma Group International Unsponsored ADR upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International Unsponsored ADR as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Ascentage Pharma Group International Unsponsored ADR has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Ascentage Pharma Group International Unsponsored ADR EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Ascentage Pharma Group International Unsponsored ADR has ― in cash and marketable securities with 1.74B in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt1.74B
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Ascentage Pharma Group International Unsponsored ADR is $27.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$27.00
Price Target Upside33.66% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast331.22%
EPS Growth Forecast59.40%